Review article: Tourette syndrome and other tic disorders in childhood, adolescence and adulthood;Übersichtsarbeit: Tourette-syndrom und andere tic-störungen in kindheit, jugend und erwachsenenalter

Deutsches Arzteblatt International

Volumn 109, Issue 48, 2012, Pages 821-828

  Ludolph, Andrea G ^a   Roessner, Veit ^b   Münchau, Alexander ^c   Müller Vahl, Kirsten ^d  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CHILD; GILLES DE LA TOURETTE SYNDROME; HUMAN; REVIEW; TIC;

EID: 84871699068     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Müller-Vahl K: Tourette-Syndrom und andere Tic-Erkrankungen im Kindes- und Erwachsenenalter. 1st edition. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft 2010.
2. Banaschewski T, Woerner W, Rothenberger A: Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents. Dev Med Child Neurol 2003; 45: 700-3. (Pubitemid 37168173)
3. Freeman RD, Zinner SH, Müller-Vahl KR, Fast DK, Burd LJ, Kano Y, et al.: Coprophenomena in Tourette syndrome. Dev Med Child Neurol 2009; 51: 218-27.
4. Robertson MM: The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res 2008; 65: 461-72.
5. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P: An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000; 42: 436-47. (Pubitemid 30427051)
6. Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T: Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol 2012; 47: 77-90.
7. Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, et al.: European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry 2011; 20: 155-71.
8. Khalifa N, von Knorring AL: Psychopathology in a Swedish population of school children with tic disorders. J Am Acad Child Adolesc Psychiatry 2006; 45: 1346-53. (Pubitemid 44665452)
9. Müller-Vahl K, Dodel I, Müller N, Münchau A, Reese JP, Balzer-Geldsetzer M, et al.: Health-related quality of life in patients with Gilles de la Tourette's syndrome. Mov Disord 2010; 25: 309-14.
10. Pringsheim T, Lang A, Kurlan R, Pearce M, Sandor P: Understanding disability in Tourette syndrome. Dev Med Child Neurol 2009; 51: 468-72.
11. Ludolph AG, Juengling FD, Libal G, Ludolph AC, Fegert JM, Kassubek J: Grey-matter abnormalities in boys with Tourette syndrome: magnetic resonance imaging study using optimised voxel-based morphometry. Br J Psychiatry 2006; 188: 484-5.
12. Thomalla G, Siebner HR, Jonas M, Bäumer T, Biermann-Ruben K, Hummel F, et al.: Structural changes in the somatosensory system correlate with tic severity in Gilles de la Tourette syndrome. Brain 2009; 132: 765-77.
13. Ludolph AG, Pinkhardt EH, Tebartz van Elst L, Libal G, Ludolph AC, Fegert JM, et al.: Are amygdalar volume alterations in children with Tourette syndrome due to ADHD comorbidity? Dev Med Child Neurol 2008; 50: 524-9. (Pubitemid 351973636)
14. Yeh CB, Lee CS, Ma KH, Lee MS, Chang CJ, Huang WS: Phasic dysfunction of dopamine transmission in Tourette's syndrome evaluated with 99mTc TRODAT-1 imaging. Psychiatry Res 2007; 156: 75-82.
15. Müller-Vahl KR, Meyer GJ, Knapp WH, Emrich HM, Gielow P, Brücke T, et al.: Serotonin transporter binding in Tourette Syndrome. Neurosci Lett 2005; 385: 120-5. (Pubitemid 40961647)
16. Tourette Syndrome Association International Consortium for Genetics. Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. Am J Hum Genet 2007; 80: 265-72.
17. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, et al.: Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005; 310: 317-20. (Pubitemid 41457198)
18. Scharf JM, Moorjani P, Fagerness J, Platko JV, Illmann C, Galloway B, et al.: Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample. Neurology 2008; 70: 1495-6. (Pubitemid 351521947)
19. Ercan-Sencicek AG, Stillman AA, Ghosh AK, Bilguvar K, O'Roak BJ, Mason CE, et al.: L-histidine decarboxylase and Tourette's syndrome. N Engl J Med 2010; 362: 1901-8.
20. Martino D, Dale RC, Gilbert DL, Giovannoni G, Leckman JF: Immunopathogenic mechanisms in tourette syndrome: A critical review. Mov Disord 2009; 24: 1267-79.
21. Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G, et al.: Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000; 39: 292-9. (Pubitemid 30127607)
22. Dion Y, Annable L, Sandor P, Chouinard G: Risperidone in the treatment of tourette syndrome: a doubleblind, placebo-controlled trial. J Clin Psychopharmacol 2002; 22: 31-9. (Pubitemid 34101290)
23. Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS: A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003; 60: 1130-5. (Pubitemid 36418773)
24. Verdellen C, van de Griendt J, Hartmann A, Murphy T: European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 2011; 20: 197-207.
25. Piacentini J, Woods DW, Scahill L, et al.: Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA 2010; 303: 1929-37.
26. Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, et al.: European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry 2011; 20: 173-96.
27. Robertson MM, Schnieden V, Lees AJ: Management of Gilles de la Tourette syndrome using sulpiride. Clin Neuropharmacol 1990; 13: 229-35. (Pubitemid 20181214)
28. Müller-Vahl KR: Die Benzamide Tiaprid, Sulpirid und Amisulprid in der Therapie des Tourette-Syndroms. Nervenarzt 2007; 78: 264-71. (Pubitemid 46376490)
29. Pringsheim T, Doja A, Gorman D, et al.: Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Can J Psychiatry 2012; 57: 133-43.
30. Müller-Vahl KR, Cath DC, Cavanna AE, Dehning S, Porta M, Robertson MM, et al.: European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry 2011; 20: 209-17.
31. Steeves T, McKinlay BD, Gorman D, et al.: Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry 2012; 57: 144-51.
32. Kuhn J, Gründler TOJ, Lenartz D, Sturm V, Klosterkötter J, Huff W: Tiefe Hirnstimulation bei psychiatrischen Erkrankungen. Dtsch Arztebl Int 2010; 107(7): 105-13.